Washington Trust’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-528
| Closed | -$79.5K | – | 350 |
|
|
2025
Q1 | $79.5K | Hold |
528
| – | – | ﹤0.01% | 351 |
|
|
2024
Q4 | $97.5K | Sell |
528
-1
| -0.2% | -$185 | ﹤0.01% | 343 |
|
|
2024
Q3 | $104K | Buy |
529
+2
| +0.4% | +$394 | ﹤0.01% | 348 |
|
|
2024
Q2 | $109K | Buy |
527
+4
| +0.8% | +$826 | ﹤0.01% | 338 |
|
|
2024
Q1 | $142K | Sell |
523
-1
| -0.2% | -$271 | 0.01% | 305 |
|
|
2023
Q4 | $124K | Buy |
524
+24
| +5% | +$5.67K | ﹤0.01% | 307 |
|
|
2023
Q3 | $98K | Hold |
500
| – | – | ﹤0.01% | 309 |
|
|
2023
Q2 | $105K | Hold |
500
| – | – | ﹤0.01% | 315 |
|
|
2023
Q1 | $101K | Hold |
500
| – | – | ﹤0.01% | 320 |
|
|
2022
Q4 | $109K | Hold |
500
| – | – | 0.01% | 302 |
|
|
2022
Q3 | $98K | Hold |
500
| – | – | ﹤0.01% | 302 |
|
|
2022
Q2 | $107K | Hold |
500
| – | – | 0.01% | 300 |
|
|
2022
Q1 | $142K | Hold |
500
| – | – | 0.01% | 295 |
|
|
2021
Q4 | $188K | Hold |
500
| – | – | 0.01% | 270 |
|
|
2021
Q3 | $206K | Hold |
500
| – | – | 0.01% | 311 |
|
|
2021
Q2 | $185K | Sell |
500
-130
| -21% | -$48.1K | 0.01% | 318 |
|
|
2021
Q1 | $183K | Buy |
630
+130
| +26% | +$37.8K | 0.01% | 309 |
|
|
2020
Q4 | $125K | Hold |
500
| – | – | ﹤0.01% | 341 |
|
|
2020
Q3 | $113K | Hold |
500
| – | – | ﹤0.01% | 326 |
|
|
2020
Q2 | $85K | Sell |
500
-15
| -3% | -$2.55K | ﹤0.01% | 316 |
|
|
2020
Q1 | $65K | Buy |
+515
| New | +$65K | ﹤0.01% | 356 |
|
|
2018
Q3 | – | Sell |
-500
| Closed | -$56K | – | 362 |
|
|
2018
Q2 | $56K | Buy |
+500
| New | +$56K | ﹤0.01% | 393 |
|